MarketInOut Stock Screener Log In | Sign Up

3B Blackbio Dx Ltd

BSE • Healthcare • Biotechnology • Quote as of 10/27/2026 15:50
3B Blackbio Dx Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeBSE
Market Capitalization11,440 mln
Float3.09 mln

EPS

65.81
Exceptional

P / E

21.26
Premium valuation

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.27
Borderline

Relative Strength

13 / 100
Significantly lagging

Debt / Equity

0.02
Debt-free

Business Description

Founded in 1972 and based in Bhopal, India, 3B Blackbio Dx Limited develops and sells medical testing products that help detect infectious diseases, cancer, genetic conditions, and antibiotic resistance. The company's testing kits, sold under the TRUPCR, TRUNGS, and TRURAPID brands, are used by diagnostic laboratories across India. Beyond medical diagnostics, the company also sells agricultural chemical products and provides technical support and training to its customers.

Key Fundamentals

EPS65.81
P/E21.26
ROE18.70
RPS180
ROIC14.75
ROA16.42
Interest Cover144
EBITDA, mln808
EV / EBITDA16.16
EV / EBIT17.50
Revenue, mln1,532
EV / Revenue8.53

Quote Details

Last 1,399.00
Change -1.75 (-0.12%)
Open 1,397.65
Volume 1,323
Turnover 1,850,877
Average Volume 4,680.52

Financial Ratios

Pre-Tax Profit Margin49
Leverage Ratio1.17
Current Ratio5.27
Price / Book4.39
Price / Tangible Book4.46
Price / Free Cash Flow54.27
Debt / Equity0.02
Price / Sales9.49

Financial Strength

Altman Z-Score20.74
Piotroski F-Score 5 / 9
Beneish M-Score-2.27
Price to Intrinsic Value1.90
Price to Lynch Fair Value4.97
Price to Graham Number2.22
Shiller PE Ratio33.89

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 5.05% 93 / 100   
1 Month -0.41% 77 / 100   
2 Months 9.44% 81 / 100   
6 Months 7.17% 71 / 100   
1 Year 2.73% 74 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog